Mutual of America Capital Management LLC Has $3.81 Million Stock Holdings in Masimo Corporation (NASDAQ:MASI)

Mutual of America Capital Management LLC cut its stake in Masimo Corporation (NASDAQ:MASI) by 2.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,871 shares of the medical equipment provider’s stock after selling 603 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Masimo were worth $3,810,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently bought and sold shares of MASI. Farther Finance Advisors LLC lifted its position in Masimo by 128.9% during the 1st quarter. Farther Finance Advisors LLC now owns 206 shares of the medical equipment provider’s stock worth $35,000 after acquiring an additional 116 shares during the last quarter. NBC Securities Inc. acquired a new position in shares of Masimo during the first quarter valued at about $61,000. UMB Bank n.a. raised its position in shares of Masimo by 134.0% during the first quarter. UMB Bank n.a. now owns 447 shares of the medical equipment provider’s stock valued at $74,000 after buying an additional 256 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Masimo by 58.4% during the first quarter. GAMMA Investing LLC now owns 738 shares of the medical equipment provider’s stock valued at $123,000 after buying an additional 272 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new stake in Masimo in the fourth quarter valued at about $163,000. 85.96% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on MASI shares. Raymond James Financial lowered their target price on shares of Masimo from $204.00 to $185.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 7th. BTIG Research reaffirmed a “buy” rating on shares of Masimo in a research note on Monday, July 14th. Wall Street Zen cut shares of Masimo from a “buy” rating to a “hold” rating in a research note on Friday, May 30th. Wells Fargo & Company decreased their price objective on shares of Masimo from $205.00 to $190.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 7th. Finally, Piper Sandler increased their price target on shares of Masimo from $200.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $193.60.

Insider Buying and Selling at Masimo

In other news, COO Bilal Muhsin sold 10,000 shares of the business’s stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $163.28, for a total transaction of $1,632,800.00. Following the transaction, the chief operating officer directly owned 24,172 shares in the company, valued at $3,946,804.16. The trade was a 29.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 9.70% of the stock is owned by corporate insiders.

Masimo Trading Down 0.1%

MASI opened at $144.73 on Friday. The stock has a market capitalization of $7.86 billion, a P/E ratio of -16.99 and a beta of 1.21. Masimo Corporation has a 12 month low of $107.98 and a 12 month high of $194.88. The firm’s fifty day simple moving average is $162.47 and its 200 day simple moving average is $164.64. The company has a current ratio of 2.14, a quick ratio of 1.62 and a debt-to-equity ratio of 0.57.

Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Tuesday, August 5th. The medical equipment provider reported $1.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.11. The firm had revenue of $370.90 million for the quarter, compared to analyst estimates of $368.65 million. Masimo had a negative net margin of 24.85% and a positive return on equity of 26.54%. The company’s revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.86 EPS. As a group, research analysts anticipate that Masimo Corporation will post 4.1 EPS for the current fiscal year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.